Discovery of 4-benzoyl-1-[(4-methoxy-1H-pyrrolo[2,3-b]lpyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine (BMS-378806):: A novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions

被引:201
作者
Wang, T
Zhang, ZX
Wallace, OB
Deshpande, M
Fang, HQ
Yang, Z
Zadjura, LM
Tweedie, DL
Huang, S
Zhao, F
Ranadive, S
Robinson, BS
Gong, YF
Riccardi, K
Spicer, TP
Deminie, C
Rose, R
Wang, HGH
Blair, WS
Shi, PY
Lin, PF
Colonno, RJ
Meanwell, NA
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Discovery Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Lead Discovery, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Virol, Wallingford, CT 06492 USA
[4] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Analyt Sci, Wallingford, CT 06492 USA
[5] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA
[6] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Pharmaceut, New Brunswick, NJ 08903 USA
关键词
D O I
10.1021/jm034082o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Indole derivative 1 interferes with the interaction of the HIV surface protein gp120 with the host cell receptor CD4. The 4-fluoro derivative 2 exhibited markedly enhanced potency and was bioavailable in the rat, dog, and cynomolgus monkey when administered orally as a solution formulation. However, aqueous suspensions of 2 were poorly bioavailable, indicative of dissolution-limited absorption. The 7-azaindole derivative 3, BMS-378806, exhibited improved pharmaceutical properties while retaining the HIV-1 inhibitory profile of 2.
引用
收藏
页码:4236 / 4239
页数:4
相关论文
共 24 条
[1]   SYNTHESIS OF 4-AMINO-1-BETA-D-RIBOFURANOSYL-1H-PYRROLO[2,3-B]PYRIDINE (1-DEAZATUBERCIDIN) AS A POTENTIAL ANTI-TUMOR AGENT [J].
ANTONINI, I ;
CLAUDI, F ;
CRISTALLI, G ;
FRANCHETTI, P ;
GRIFANTINI, M ;
MARTELLI, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (10) :1258-1261
[2]   HIV-1 entry - an expanding portal for drug discovery [J].
Blair, WS ;
Lin, PF ;
Meanwell, NA ;
Wallace, OB .
DRUG DISCOVERY TODAY, 2000, 5 (05) :183-194
[3]   DESIGN AND SYNTHESIS OF A CD4 BETA-TURN MIMETIC THAT INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN GP120 BINDING AND INFECTION OF HUMAN-LYMPHOCYTES [J].
CHEN, SX ;
CHRUSCIEL, RA ;
NAKANISHI, H ;
RAKTABUTR, A ;
JOHNSON, ME ;
SATO, A ;
WEINER, D ;
HOXIE, J ;
SARAGOVI, HU ;
GREENE, MI ;
KAHN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :5872-5876
[4]  
Fanghanel E, 1996, SYNTHESIS-STUTTGART, P1375
[5]   PREVENTION OF HIV-1 INFECTION AND PRESERVATION OF CD4 FUNCTION BY THE BINDING OF CPFS TO GP120 [J].
FINBERG, RW ;
DIAMOND, DC ;
MITCHELL, DB ;
ROSENSTEIN, Y ;
SOMAN, G ;
NORMAN, TC ;
SCHREIBER, SL ;
BURAKOFF, SJ .
SCIENCE, 1990, 249 (4966) :287-291
[6]  
GAO Q, UNPUB
[7]   Structured treatment interruption in patients infected with HIV - A new approach to therapy? [J].
Gulick, RM .
DRUGS, 2002, 62 (02) :245-253
[8]   AROMATIC SUBSTITUENT CONSTANTS FOR STRUCTURE-ACTIVITY CORRELATIONS [J].
HANSCH, C ;
LEO, A ;
UNGER, SH ;
KIM, KH ;
NIKAITANI, D ;
LIEN, EJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (11) :1207-1216
[9]  
Harada N, 1997, CHEM PHARM BULL, V45, P134
[10]   STRUCTURE-DIRECTED DISCOVERY OF AN INHIBITOR OF THE BINDING OF HIV GP120 TO THE CD4 RECEPTOR [J].
JARVEST, RL ;
BREEN, AL ;
EDGE, CM ;
CHAIKIN, MA ;
JENNINGS, LJ ;
TRUNEH, A ;
SWEET, RW ;
HERTZBERG, RP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (12) :2851-2856